28099123|t|Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index
28099123|a|Hyperandrogenemia is one of the major diagnostic features for the diagnosis of polycystic ovary syndrome (PCOS). The aim of this study was to estimate the prevalence and the characteristics of hyperandrogenemia in women with PCOS and to investigate the association of clinical and biochemical characteristics with body mass index (BMI) according to the presence of hyperandrogenemia. We studied 266 women diagnosed with PCOS. Hyperandrogenemia was defined by testosterone (T) and/or free testosterone (FT) and/or ∆4 androstenedione (Δ4-A) higher than 75% of the upper limits of each hormone. Patients were stratified in two groups according to a BMI threshold of 25 kg/m2. Hyperandrogenemia was present in 78.2% of the patients. Elevated levels of T were found in 58.4%, while elevated levels of FT and Δ4-A were found in 42.5% and 34.1% of patients. In normal weight women (BMI ≤25 kg/m2) with hyperandrogenemia lower values of hip circumference and HOMA-IR and increased levels of T, FT, Δ4-A, 17-hydroxyprogesterone (17-OHP), dehydroepiandrosterone sulfate (DHEAS), white blood cells (WBC) and neutrophils were observed compared to women without hyperandrogenemia. Also, in overweight women higher levels of T, FT, Δ4-A, 17-OHP, DHEAS and cortisol were measured, while lower thyroid-stimulating hormone (TSH) levels were comparable to women without hyperandrogenemia. This study showed high prevalence of hyperandrogenemia in PCOS women. Women with BMI ≤25 kg/m2 have significant differences in androgens, WBC, neutrophils and HOMA-IR and women with BMI ≥25 kg/m2 in androgens, TSH and cortisol according to the presence or not of hyperandrogenemia.
28099123	0	17	Hyperandrogenemia	T033	UMLS:C1299574
28099123	21	26	women	T098	UMLS:C0043210
28099123	32	57	polycystic ovary syndrome	T038	UMLS:C0032460
28099123	108	123	body mass index	T201	UMLS:C1305855
28099123	124	141	Hyperandrogenemia	T033	UMLS:C1299574
28099123	190	199	diagnosis	T033	UMLS:C0011900
28099123	203	228	polycystic ovary syndrome	T038	UMLS:C0032460
28099123	230	234	PCOS	T038	UMLS:C0032460
28099123	317	334	hyperandrogenemia	T033	UMLS:C1299574
28099123	338	343	women	T098	UMLS:C0043210
28099123	349	353	PCOS	T038	UMLS:C0032460
28099123	438	453	body mass index	T201	UMLS:C1305855
28099123	455	458	BMI	T201	UMLS:C1305855
28099123	477	485	presence	T033	UMLS:C0150312
28099123	489	506	hyperandrogenemia	T033	UMLS:C1299574
28099123	523	528	women	T098	UMLS:C0043210
28099123	529	538	diagnosed	T033	UMLS:C0011900
28099123	544	548	PCOS	T038	UMLS:C0032460
28099123	550	567	Hyperandrogenemia	T033	UMLS:C1299574
28099123	583	595	testosterone	T103	UMLS:C0039601
28099123	597	598	T	T103	UMLS:C0039601
28099123	607	624	free testosterone	T103	UMLS:C0443483
28099123	626	628	FT	T103	UMLS:C0443483
28099123	637	655	∆4 androstenedione	T103	UMLS:C4284099
28099123	657	661	Δ4-A	T103	UMLS:C4284099
28099123	707	714	hormone	T103	UMLS:C0019932
28099123	748	754	groups	T098	UMLS:C1257890
28099123	770	773	BMI	T201	UMLS:C1305855
28099123	797	814	Hyperandrogenemia	T033	UMLS:C1299574
28099123	819	826	present	T033	UMLS:C0150312
28099123	872	873	T	T103	UMLS:C0039601
28099123	920	922	FT	T103	UMLS:C0443483
28099123	927	931	Δ4-A	T103	UMLS:C4284099
28099123	978	991	normal weight	T033	UMLS:C2712185
28099123	992	997	women	T098	UMLS:C0043210
28099123	999	1002	BMI	T201	UMLS:C1305855
28099123	1019	1036	hyperandrogenemia	T033	UMLS:C1299574
28099123	1053	1070	hip circumference	T201	UMLS:C0562350
28099123	1075	1082	HOMA-IR	T058	UMLS:C3639411
28099123	1107	1108	T	T103	UMLS:C0039601
28099123	1110	1112	FT	T103	UMLS:C0443483
28099123	1114	1118	Δ4-A	T103	UMLS:C4284099
28099123	1120	1142	17-hydroxyprogesterone	T103	UMLS:C0045010
28099123	1144	1150	17-OHP	T103	UMLS:C0045010
28099123	1153	1183	dehydroepiandrosterone sulfate	T103	UMLS:C0057277
28099123	1185	1190	DHEAS	T103	UMLS:C0057277
28099123	1193	1210	white blood cells	T017	UMLS:C0023516
28099123	1212	1215	WBC	T017	UMLS:C0023516
28099123	1221	1232	neutrophils	T017	UMLS:C0027950
28099123	1259	1264	women	T098	UMLS:C0043210
28099123	1273	1290	hyperandrogenemia	T033	UMLS:C1299574
28099123	1301	1311	overweight	T033	UMLS:C0497406
28099123	1312	1317	women	T098	UMLS:C0043210
28099123	1335	1336	T	T103	UMLS:C0039601
28099123	1338	1340	FT	T103	UMLS:C0443483
28099123	1342	1346	Δ4-A	T103	UMLS:C4284099
28099123	1348	1354	17-OHP	T103	UMLS:C0045010
28099123	1356	1361	DHEAS	T103	UMLS:C0057277
28099123	1366	1374	cortisol	T103	UMLS:C0020268
28099123	1402	1442	thyroid-stimulating hormone (TSH) levels	T058	UMLS:C0202230
28099123	1462	1467	women	T098	UMLS:C0043210
28099123	1476	1493	hyperandrogenemia	T033	UMLS:C1299574
28099123	1532	1549	hyperandrogenemia	T033	UMLS:C1299574
28099123	1553	1557	PCOS	T038	UMLS:C0032460
28099123	1558	1563	women	T098	UMLS:C0043210
28099123	1565	1570	Women	T098	UMLS:C0043210
28099123	1576	1579	BMI	T201	UMLS:C1305855
28099123	1622	1631	androgens	T103	UMLS:C0002844
28099123	1633	1636	WBC	T017	UMLS:C0023516
28099123	1638	1649	neutrophils	T017	UMLS:C0027950
28099123	1654	1661	HOMA-IR	T058	UMLS:C3639411
28099123	1666	1671	women	T098	UMLS:C0043210
28099123	1677	1680	BMI	T201	UMLS:C1305855
28099123	1694	1703	androgens	T103	UMLS:C0002844
28099123	1705	1708	TSH	T103	UMLS:C2825077
28099123	1713	1721	cortisol	T103	UMLS:C0020268
28099123	1739	1747	presence	T033	UMLS:C0150312
28099123	1758	1775	hyperandrogenemia	T033	UMLS:C1299574